Terms: = Kidney tumors AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987
120 results:
1. Primary follicular dendritic cell sarcoma of the kidney - a case report of a rare tumor with emphasis on diagnostic pitfalls.
Pancsa T; Dénes B; Somorácz Á; Kelemen D; Salamon F; Sánta F; Kuthi L
Diagn Pathol; 2024 Jan; 19(1):24. PubMed ID: 38297323
[TBL] [Abstract] [Full Text] [Related]
2. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
3. Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification.
Lin R; Flerova E; Wamsley CE; McCue PA; Lallas CD; Jiang W; Huang J; Wang ZX; Li L
Genes Chromosomes Cancer; 2023 Jun; 62(6):353-360. PubMed ID: 36704911
[TBL] [Abstract] [Full Text] [Related]
4. Assessment of cancer-related signaling pathways in responses to polystyrene nanoplastics via a kidney-testis microfluidic platform (KTP).
Xiao M; Li X; Zhang X; Duan X; Lin H; Liu S; Sui G
Sci Total Environ; 2023 Jan; 857(Pt 1):159306. PubMed ID: 36216064
[TBL] [Abstract] [Full Text] [Related]
5. CHMP1A suppresses the growth of renal cell carcinoma cells via regulation of the PI3K/mTOR/p53 signaling pathway.
Wu Y; Wu Y; Xu C; Sun W; You Z; Wang Y; Zhang S
Genes Genomics; 2022 Jul; 44(7):823-832. PubMed ID: 35583792
[TBL] [Abstract] [Full Text] [Related]
6. Molecular imaging and treatment of PSMA-positive prostate cancer with
Jiao Y; Xu P; Luan S; Wang X; Gao Y; Zhao C; Fu P
Nucl Med Biol; 2022; 104-105():28-37. PubMed ID: 34847481
[TBL] [Abstract] [Full Text] [Related]
7. Soft tissue perineurioma involving the kidney: a report of two cases with an emphasis on differential diagnosis.
Ma TS; Zhou L; Zhou Q; He XL; Zhao M
Diagn Pathol; 2021 Sep; 16(1):87. PubMed ID: 34592995
[TBL] [Abstract] [Full Text] [Related]
8. kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, mdm2, MDM4, p53, KRAS and AKT in renal cell carcinoma.
Li F; Aljahdali IAM; Zhang R; Nastiuk KL; Krolewski JJ; Ling X
J Exp Clin Cancer Res; 2021 Aug; 40(1):254. PubMed ID: 34384473
[TBL] [Abstract] [Full Text] [Related]
9. Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Koeppen H; Coates PJ
J Pathol; 2021 Jul; 254(4):303-306. PubMed ID: 34097314
[TBL] [Abstract] [Full Text] [Related]
10. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
[TBL] [Abstract] [Full Text] [Related]
11. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap.
Shi B; Ding J; Qi J; Gu Z
Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477
[TBL] [Abstract] [Full Text] [Related]
12. MiR-6838-5p facilitates the proliferation and invasion of renal cell carcinoma cells through inhibiting the DMTF1/ARF-p53 axis.
Zhai X; Wu Y; Zhang D; Li H; Chong T; Zhao J
J Bioenerg Biomembr; 2021 Apr; 53(2):191-202. PubMed ID: 33686550
[TBL] [Abstract] [Full Text] [Related]
13. Synchronous Renal Dedifferentiated Liposarcoma and Retroperitoneal Well-Differentiated Liposarcoma: A Case Report With Literature Review.
Nie L; Chen X; Gong J; Zhang M; Xu M; Chen N; Zhou Q
Int J Surg Pathol; 2021 Sep; 29(6):667-671. PubMed ID: 33355009
[TBL] [Abstract] [Full Text] [Related]
14. B-MYB-p53-related relevant regulator for the progression of clear cell renal cell carcinoma.
Nientiedt M; Müller K; Nitschke K; Erben P; Steidler A; Porubsky S; Popovic ZV; Waldbillig F; Mühlbauer J; Kriegmair MC
J Cancer Res Clin Oncol; 2021 Jan; 147(1):129-138. PubMed ID: 32951068
[TBL] [Abstract] [Full Text] [Related]
15. UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.
Liu J; Guan D; Dong M; Yang J; Wei H; Liang Q; Song L; Xu L; Bai J; Liu C; Mao J; Zhang Q; Zhou J; Wu X; Wang M; Cong YS
Nat Cell Biol; 2020 Sep; 22(9):1056-1063. PubMed ID: 32807901
[TBL] [Abstract] [Full Text] [Related]
16. Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.
Kawata Y; Nagasaka K; Oda K; Makii C; Takeuchi M; Oki S; Honjo H; Kojima M; Miyagawa Y; Taguchi A; Tanikawa M; Sone K; Hiraike H; Matsumoto Y; Wada-Hiraike O; Ayabe T; Osuga Y; Fujii T
Cancer Sci; 2020 Oct; 111(10):3824-3834. PubMed ID: 32713096
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of Transglutaminase 2 but Not of mdm2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma.
Kang JH; Lee SH; Lee JS; Oh SJ; Ha JS; Choi HJ; Kim SY
Cells; 2020 Jun; 9(6):. PubMed ID: 32560270
[TBL] [Abstract] [Full Text] [Related]
18. Rare mdm2 amplification in a fat-predominant angiomyolipoma.
Rodriguez Pena MDC; Gordetsky J; Greipp PT; Wei S; Martignoni G; Netto GJ; Harada S; Prieto Granada CN
Virchows Arch; 2020 Nov; 477(5):661-666. PubMed ID: 32409886
[TBL] [Abstract] [Full Text] [Related]
19. β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-mdm2 Interaction in Colorectal Cancer.
Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K
J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760
[TBL] [Abstract] [Full Text] [Related]
20. [Retroperitoneal Dedifferentiated Liposarcoma which Could Be Diagnosed Using Dual Color in Situ Hybridization : A Case Report].
Iinuma K; Hishida S; Ito H; Taniguchi T; Takai M; Kato D; Muramatsu Maekawa Y; Nakane K; Kato T; Mizutani K; Tsuchiya T; Higashi T; Murase K; Suzui N; Miyazaki T; Koie T
Hinyokika Kiyo; 2020 Feb; 66(2):45-48. PubMed ID: 32160732
[TBL] [Abstract] [Full Text] [Related]
[Next]
